Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.

Roxburgh A, Hall WD, Gisev N, Degenhardt L.

Drug Alcohol Depend. 2019 Dec 1;205:107533. doi: 10.1016/j.drugalcdep.2019.06.035. Epub 2019 Oct 22.

PMID:
31704378
2.

Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.

Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L.

Lancet Psychiatry. 2019 Dec;6(12):995-1010. doi: 10.1016/S2215-0366(19)30401-8. Epub 2019 Oct 28. Erratum in: Lancet Psychiatry. 2020 Jan;7(1):e3.

PMID:
31672337
3.

Social, demographic, and economic correlates of food and chemical consumption measured by wastewater-based epidemiology.

Choi PM, Tscharke B, Samanipour S, Hall WD, Gartner CE, Mueller JF, Thomas KV, O'Brien JW.

Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21864-21873. doi: 10.1073/pnas.1910242116. Epub 2019 Oct 7.

4.

Reducing the risks of distortion in cannabis research.

Humphreys K, Hall WD.

Addiction. 2019 Sep 6. doi: 10.1111/add.14801. [Epub ahead of print] No abstract available.

PMID:
31491039
5.

Commentary on Burgard et al. (2019): Wastewater based estimates of the size of illicit markets for psychoactive drugs.

O'Brien JW, Hall WD.

Addiction. 2019 Sep;114(9):1591-1592. doi: 10.1111/add.14716. Epub 2019 Jul 19. No abstract available.

PMID:
31321822
6.

Antidepressant Use Among People Prescribed Opioids for Chronic Noncancer Pain.

Gisev N, Nielsen S, Campbell G, Santo T, Mant A, Bruno R, Cohen M, Hall WD, Larance B, Lintzeris N, Farrell M, Degenhardt L.

Pain Med. 2019 Dec 1;20(12):2450-2458. doi: 10.1093/pm/pnz009.

PMID:
30861530
7.

Can automated content analysis be used to assess and improve the use of evidence in mental health policy? A systematic review.

Alla K, Oprescu F, Hall WD, Whiteford HA, Head BW, Meurk CS.

Syst Rev. 2018 Nov 15;7(1):194. doi: 10.1186/s13643-018-0853-z.

8.

The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications.

Hall WD, Farrell M.

Med J Aust. 2018 Aug 3;209(5):209-210. No abstract available.

PMID:
30157412
9.

Reducing the opioid overdose death toll in North America.

Hall WD, Farrell M.

PLoS Med. 2018 Jul 31;15(7):e1002626. doi: 10.1371/journal.pmed.1002626. eCollection 2018 Jul.

10.

Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy.

Qian G, Yao W, Zhang S, Bajpai R, Hall WD, Shanmugam M, Lonial S, Sun SY.

Cancer Lett. 2018 Oct 28;435:44-54. doi: 10.1016/j.canlet.2018.07.033. Epub 2018 Jul 29.

PMID:
30059709
11.

Amphetamine use in the fourth decade of life: Social profiles from a population-based Australian cohort.

Butterworth P, Becker D, Degenhardt L, Hall WD, Patton GC.

Drug Alcohol Rev. 2018 Sep;37(6):743-751. doi: 10.1111/dar.12840. Epub 2018 Jul 11.

PMID:
29998467
12.

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L.

Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.

13.

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.

Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L.

Pain. 2018 Oct;159(10):1932-1954. doi: 10.1097/j.pain.0000000000001293.

PMID:
29847469
14.

Adverse adult consequences of different alcohol use patterns in adolescence: an integrative analysis of data to age 30 years from four Australasian cohorts.

Silins E, Horwood LJ, Najman JM, Patton GC, Toumbourou JW, Olsson CA, Hutchinson DM, Degenhardt L, Fergusson D, Becker D, Boden JM, Borschmann R, Plotnikova M, Youssef GJ, Tait RJ, Clare P, Hall WD, Mattick RP; Cannabis Cohorts Research Consortium.

Addiction. 2018 Oct;113(10):1811-1825. doi: 10.1111/add.14263. Epub 2018 Jun 19.

PMID:
29749666
15.

Accurate identification of opioid overdose deaths using coronial data.

Roxburgh A, Pilgrim JL, Hall WD, Burns L, Degenhardt L.

Forensic Sci Int. 2018 Jun;287:40-46. doi: 10.1016/j.forsciint.2018.03.032. Epub 2018 Mar 26.

PMID:
29627712
16.

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.

Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753. doi: 10.1136/jnnp-2017-317168. Epub 2018 Mar 6.

PMID:
29511052
17.

Understanding the true economic impact of self-harming behaviour.

Kinchin I, Doran CM, Hall WD, Meurk C.

Lancet Psychiatry. 2017 Dec;4(12):900-901. doi: 10.1016/S2215-0366(17)30411-X. No abstract available.

PMID:
29179929
18.

How do we define the policy impact of public health research? A systematic review.

Alla K, Hall WD, Whiteford HA, Head BW, Meurk CS.

Health Res Policy Syst. 2017 Oct 2;15(1):84. doi: 10.1186/s12961-017-0247-z. Review.

19.

Trends in heroin and pharmaceutical opioid overdose deaths in Australia.

Roxburgh A, Hall WD, Dobbins T, Gisev N, Burns L, Pearson S, Degenhardt L.

Drug Alcohol Depend. 2017 Oct 1;179:291-298. doi: 10.1016/j.drugalcdep.2017.07.018. Epub 2017 Aug 14.

PMID:
28826104
20.

An analysis of policy success and failure in formal evaluations of Australia's national mental health strategy (1992-2012).

Grace FC, Meurk CS, Head BW, Hall WD, Harris MG, Whiteford HA.

BMC Health Serv Res. 2017 May 30;17(1):374. doi: 10.1186/s12913-017-2309-x.

21.

Alcohol problems need more attention in patients receiving long-term opioid substitution therapy.

Hall WD, Strang J.

Lancet Psychiatry. 2017 Apr;4(4):265-266. doi: 10.1016/S2215-0366(17)30073-1. Epub 2017 Mar 1. No abstract available.

PMID:
28258832
22.

Reducing alcohol-related violence and other harm in Australia.

Hall WD, Weier M.

Med J Aust. 2017 Feb 20;206(3):111-112. No abstract available.

PMID:
28208035
23.

Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.

McKetin R, Degenhardt L, Hall WD.

Med J Aust. 2016 Nov 7;205(9):426. No abstract available.

PMID:
27809743
24.

Trend in alcohol use in Australia over 13 years: has there been a trend reversal?

Chan GC, Leung JK, Quinn C, Connor JP, Hides L, Gullo MJ, Alati R, Weier M, Kelly AB, Hall WD.

BMC Public Health. 2016 Oct 10;16(1):1070.

25.

The challenge of reducing smoking in people with serious mental illness.

Sharma R, Gartner CE, Hall WD.

Lancet Respir Med. 2016 Oct;4(10):835-844. doi: 10.1016/S2213-2600(16)30228-4. Review.

PMID:
27707462
26.

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.

Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, Vos T.

Lancet Infect Dis. 2016 Dec;16(12):1385-1398. doi: 10.1016/S1473-3099(16)30325-5. Epub 2016 Sep 21.

27.

Crystalline methamphetamine use and methamphetamine-related harms in Australia.

Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD.

Drug Alcohol Rev. 2017 Mar;36(2):160-170. doi: 10.1111/dar.12426. Epub 2016 Jun 11.

PMID:
27286742
28.

Illicit Drug Dependence.

Degenhardt L, Stockings E, Strang J, Marsden J, Hall WD.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 6.

29.

Does parental monitoring and disapproval explain variations in alcohol use among adolescents from different countries of birth?

Chan GC, Kelly AB, Connor JP, Hall WD, Young RM, Williams JW.

Drug Alcohol Rev. 2016 Nov;35(6):741-749. doi: 10.1111/dar.12413. Epub 2016 May 24.

PMID:
27220010
30.

Parental supply of alcohol to Australian minors: an analysis of six nationally representative surveys spanning 15 years.

Kelly AB, Chan GC, Weier M, Quinn C, Gullo MJ, Connor JP, Hall WD.

BMC Public Health. 2016 Apr 14;16:325. doi: 10.1186/s12889-016-3004-2.

31.

Commentary on Imtiaz et al. (2016): The burden of disease attributable to cannabis-implications for policy.

Hall WD.

Addiction. 2016 Apr;111(4):663-4. doi: 10.1111/add.13272. No abstract available.

PMID:
26995175
32.

Commentary on Ogeil et al. (2016): Explaining increased alcohol-related harm and stable per capita consumption in Australia.

Hall WD, Chan G.

Addiction. 2016 Apr;111(4):635-6. doi: 10.1111/add.13246. No abstract available. Erratum in: Addiction. 2016 Sep;111(9):1689.

PMID:
26995174
33.

Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.

Degenhardt L, Larney S, Chan G, Dobbins T, Weier M, Roxburgh A, Hall WD, McKetin R.

Med J Aust. 2016 Mar 7;204(4):153.

PMID:
26937668
34.

Trends in methamphetamine residues in wastewater in metropolitan and regional cities in south-east Queensland, 2009-2015.

Lai FY, O'Brien J, Thai PK, Hall WD, Mueller J.

Med J Aust. 2016 Mar 7;204(4):151-2. No abstract available.

PMID:
26937667
35.

Why young people's substance use matters for global health.

Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L.

Lancet Psychiatry. 2016 Mar;3(3):265-79. doi: 10.1016/S2215-0366(16)00013-4. Epub 2016 Feb 18. Review.

PMID:
26905482
36.

Prevention, early intervention, harm reduction, and treatment of substance use in young people.

Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L.

Lancet Psychiatry. 2016 Mar;3(3):280-96. doi: 10.1016/S2215-0366(16)00002-X. Epub 2016 Feb 18. Review.

PMID:
26905481
37.

The increasing global health priority of substance use in young people.

Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M.

Lancet Psychiatry. 2016 Mar;3(3):251-64. doi: 10.1016/S2215-0366(15)00508-8. Epub 2016 Feb 18. Review.

PMID:
26905480
38.

Does the social context of early alcohol use affect risky drinking in adolescents? Prospective cohort study.

Degenhardt L, Romaniuk H, Coffey C, Hall WD, Swift W, Carlin JB, O'Loughlin C, Patton GC.

BMC Public Health. 2015 Nov 16;15:1137. doi: 10.1186/s12889-015-2443-5.

39.

An analysis of policy levers used to implement mental health reform in Australia 1992-2012.

Grace FC, Meurk CS, Head BW, Hall WD, Carstensen G, Harris MG, Whiteford HA.

BMC Health Serv Res. 2015 Oct 24;15:479. doi: 10.1186/s12913-015-1142-3.

40.

Rural and Urban Differences in Adolescent Alcohol Use, Alcohol Supply, and Parental Drinking.

Chan GC, Leung J, Quinn C, Kelly AB, Connor JP, Weier M, Hall WD.

J Rural Health. 2016 Jun;32(3):280-6. doi: 10.1111/jrh.12151. Epub 2015 Oct 8.

PMID:
26450773
41.

Trends and characteristics of accidental and intentional codeine overdose deaths in Australia.

Roxburgh A, Hall WD, Burns L, Pilgrim J, Saar E, Nielsen S, Degenhardt L.

Med J Aust. 2015 Oct 5;203(7):299.

PMID:
26424067
42.

Alcohol use disorders.

Connor JP, Haber PS, Hall WD.

Lancet. 2016 Mar 5;387(10022):988-998. doi: 10.1016/S0140-6736(15)00122-1. Epub 2015 Sep 3. Review. Erratum in: Lancet. 2016 Mar 5;387(10022):944. Erratum in: Lancet. 2016 Mar 5;387(10022):944.

PMID:
26343838
43.

Opioid analgesic prescribing in Australia: a focus on gender and age.

Hollingworth SA, Gray PD, Hall WD, Najman JM.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):628-36. doi: 10.1002/pds.3767. Epub 2015 Apr 1.

PMID:
25845470
44.

Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study.

Degenhardt L, Lintzeris N, Campbell G, Bruno R, Cohen M, Farrell M, Hall WD.

Drug Alcohol Depend. 2015 Feb 1;147:144-50. doi: 10.1016/j.drugalcdep.2014.11.031. Epub 2014 Dec 10.

PMID:
25533893
45.

Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.

Sara GE, Large MM, Matheson SL, Burgess PM, Malhi GS, Whiteford HA, Hall WD.

Aust N Z J Psychiatry. 2015 Feb;49(2):106-17. doi: 10.1177/0004867414561526. Epub 2014 Dec 17. Review.

PMID:
25518844
46.

A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion.

Kelly AB, Evans-Whipp TJ, Smith R, Chan GC, Toumbourou JW, Patton GC, Hemphill SA, Hall WD, Catalano RF.

Addiction. 2015 Apr;110(4):627-35. doi: 10.1111/add.12829. Epub 2015 Jan 26.

47.

Food addiction and its impact on weight-based stigma and the treatment of obese individuals in the U.S. and Australia.

Lee NM, Hall WD, Lucke J, Forlini C, Carter A.

Nutrients. 2014 Nov 21;6(11):5312-26. doi: 10.3390/nu6115312.

48.

Afghanistan has a sizeable problem with opioid use.

Hall WD, Degenhardt L.

Lancet Glob Health. 2014 Oct;2(10):e557-8. doi: 10.1016/S2214-109X(14)70299-2. No abstract available.

49.

Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence.

Degenhardt L, Mathers B, Hall WD.

Addiction. 2014 Aug;109(8):1335-7. doi: 10.1111/add.12612. No abstract available.

PMID:
25041204
50.

Generational increase in young women's drinking: a prospective analysis of mother-daughter dyads.

Alati R, Betts KS, Williams GM, Najman JM, Hall WD.

JAMA Psychiatry. 2014 Aug;71(8):952-7. doi: 10.1001/jamapsychiatry.2014.513.

PMID:
24965043

Supplemental Content

Support Center